Health Insurance Lead Pricing in 2026: ACA, Medicare Advantage, and Medicare Supplement

Health insurance lead pricing in 2026 is a story split in half. There's the pricing — $0.50 to $150 per record across the sub-markets — and there's the regulatory frame that determines whether the pricing is even useful to you. The CMS TPMO consent rule that took effect October 1, 2024 fundamentally changed what an "aged Medicare Advantage lead" can legally be used for, and that's the part most cost-comparison articles still don't talk about.

This article walks both sides. Pricing tier by tier across ACA marketplace, Medicare Supplement, and Medicare Advantage. Then the compliance frame that decides which tier actually fits your operation. The bottom line, for most independent agents writing senior health and Medicare in 2026: the pricing math still favors aged inventory dramatically, but the operating model is more nuanced than it was three years ago.

Three sub-markets, three different environments

Before the pricing, it's worth understanding why "health insurance leads" doesn't describe one market.

ACA / marketplace is the under-65 individual health market. The cycle is anchored to the annual Open Enrollment Period (November 1 to January 15) plus year-round Special Enrollment Periods triggered by life events. Standard TCPA framework applies. No CMS marketing overlay.

Medicare Supplement (MedSupp) is the senior market for plans that wrap around Original Medicare. Year-round market with timing nuances around the Initial Enrollment Period at age 65, Guaranteed Issue periods, and Birthday Rule states (California, Oregon, Washington, Idaho, Kentucky, Louisiana, Maryland, Maine, Missouri, Nevada, and Oklahoma). MedSupp is regulated by state insurance commissioners and standardized federal plan letters — it's not subject to the CMS marketing rules that govern Medicare Advantage.

Medicare Advantage (MA / MAPD) is the senior market for the Part C alternative to Original Medicare. Cycles around the Annual Election Period (October 15 to December 7), the Medicare Advantage Open Enrollment Period (January 1 to March 31), and Special Enrollment Periods. Heavy CMS marketing-rule overlay including the TPMO consent rule that's the single biggest operational change to this market in 2026.

Three different consumers, three different sales cycles, three different regulatory environments. Pricing reflects that.

The 2026 health insurance lead pricing table

Here's the full picture across all three sub-markets:

Two things to note from the table.

The aged-to-real-time discount is consistent with other insurance verticals — roughly 10-30x. ACA aged at $0.75 versus real-time at $30 is a 40x spread. MedSupp aged at $3 versus real-time at $35 is a 12x spread. MA aged at $4 versus real-time at $45 is an 11x spread.

Aged Medicare Supplement and aged Medicare Advantage are priced similarly per record, but they're operationally very different products in 2026. That's the part the pricing table can't tell you.

The CMS TPMO consent rule — why aged Medicare Advantage isn't what it used to be

This is the section that earns the article.

In April 2024, CMS published the CY 2025 Medicare Advantage and Part D final rule (CMS-4205-F). Effective October 1, 2024, the rule imposed a new consent regime on third-party marketing organizations — TPMOs — which CMS defines broadly to include independent agents and brokers as well as commercial lead generators. The rule was carried forward into the CY 2026 final rule (CMS-4208-F).

The core requirement: a TPMO must obtain prior express written consent from a Medicare beneficiary before sharing that beneficiary's personal data with another TPMO for purposes of marketing or enrolling the beneficiary into a Medicare Advantage or Part D plan. The consent must be obtained separately for each downstream TPMO that receives the data, through a clear and conspicuous disclosure. Blanket "I agree to be contacted by partners" consent is no longer sufficient.

That changes what an aged Medicare Advantage lead actually is.

Many aged MA leads sold today were originated under the old broad-consent regime — pre-October 2024 forms where the consumer agreed to be contacted by "partner companies" or similar boilerplate. Under TCPA, the original form-fill consent travels with the record and remains valid for outbound contact. But the CMS overlay specifically restricts what a TPMO can do during that contact for MA enrollment purposes. You can call. You can have a general informational conversation. You cannot use the broad legacy consent to support an enrollment-related conversation if you're a downstream TPMO without separate per-TPMO consent.

In practice, this has split the aged-MA market into two operational tiers:

Pre-October 2024 aged MA leads. These are still callable and still useful — but the operationally clean workflow involves treating the call as informational outreach, capturing fresh per-agent consent at the start of any enrollment-related conversation, and documenting that capture. Most aged MA buyers in 2026 use a verbal or scope-of-appointment workflow at the front of every call to refresh the consent posture.

Post-October 2024 aged MA leads. These can be cleaner, depending on the original form's consent language. Reputable aged providers should now be tagging Medicare leads with the consent regime under which they were originated, and reputable buyers are filtering for post-October 2024 inventory with TPMO-specific consent on the original form.

If your aged-lead provider can't tell you which regime a Medicare lead was originated under, or can't produce the specific consent language the consumer accepted, that's a reason to keep shopping. The market has providers who can.

Looking for leads? Compare top providers for your vertical — independent ratings across 15+ verticals.

ACA / marketplace leads — the cleanest aged inventory

ACA leads sit outside the CMS TPMO framework entirely and operate under standard TCPA rules. That makes them the simplest aged-health inventory to work with in 2026.

Pricing is $0.50-$0.94 for aged 31-85 day shared internet form, against $20-$40 for real-time shared. The OEP demand cycle creates a meaningful pricing arbitrage: real-time prices climb 20-40% in October-November as carriers and brokerages compete for the year's biggest enrollment window, while aged inventory from the prior cycle hits its lowest pricing in March-April.

The smart operational play: buy aged ACA leads in Q1-Q2 and warehouse the records in your CRM. Begin year-round SEP outreach immediately on life-event triggers (birth, marriage, divorce, job loss, geographic move). Ramp into formal OEP enrollment outreach in September, with the bulk of conversion happening November through January.

CPA math on aged ACA: at $0.75 per lead, 25% cumulative contact, and a 1.5% conversion to bound enrollment, you're at a $200 CPA against a typical $400-$650 first-year ACA commission. For a year-round SEP-focused operation, the math is durable. For an OEP-only operation, you have to compress your conversion into a 90-day window, which raises operational pressure but doesn't change the underlying CPA arithmetic.

Existing strategy on the year-round model is in Aged Health Insurance Leads: Open Enrollment and SEP Strategies for 2026.

Medicare Supplement leads — the underrated aged category

If you're writing senior health in 2026 and you're not buying aged Medicare Supplement leads, you're leaving money on the table.

MedSupp pricing is $1-$4 for aged 31-85 day shared internet form, against $25-$50 for real-time. The aged discount is large, but the real advantage is regulatory: MedSupp is not subject to the CMS TPMO marketing rule. State insurance commissioners regulate the product, and federal plan-letter standardization keeps the offering consistent — but the cross-TPMO consent regime that complicates aged MA simply doesn't apply to MedSupp.

That makes aged MedSupp the most operationally clean Medicare-segment aged category available in 2026. You buy the leads, you call them under the original form-fill consent, and you don't have to navigate a separate per-TPMO consent capture for enrollment-related conversation.

CPA math: at $3 per lead and a 3% conversion rate (realistic for an experienced agent on aged MedSupp inventory), you're at a $100 CPA against a typical $400-$700 first-year MedSupp commission. The renewal tail on MedSupp is unusually long — most plans see 80%+ year-five retention — which means the lifetime value math is even better than the first-year math suggests.

Strategic play: lead with MedSupp on aged senior leads. Cross-sell or upgrade to Medicare Advantage where appropriate timing and eligibility allow, with a clean per-TPMO consent capture at the point you transition the conversation to MA. The full year-round Medicare prospecting framework is in Year-Round Medicare Prospecting: How to Use Aged Leads Beyond AEP.

Medicare Advantage leads — the regulated path

Aged MA leads are still valuable in 2026. They're just operated differently than they used to be.

Pricing is $1.50-$8 for aged 31-85 day shared internet form. The wide range reflects the consent-regime split — pre-October 2024 inventory generally prices at the lower end, post-October 2024 inventory with TPMO-specific consent generally prices at the higher end.

Real-time MA pricing is $30-$60 shared, $75-$150 exclusive. Live transfer MA inventory at $50-$100 has held up well through the rule change because the live-transfer consent capture happens during the call itself, which simplifies the regulatory posture.

The practical workflow most aged-MA agents have settled into in 2026 looks like this:

Treat the initial outbound call as informational outreach — a conversation about Medicare options, the consumer's current coverage, and their needs. The original form-fill consent supports that conversation under TCPA.

If the conversation moves toward a specific MA enrollment, capture fresh per-TPMO consent verbally and in writing before the enrollment-specific portion of the call. Most agents now use a brief scripted consent capture at the transition point — something like a recorded verbal consent or a digital scope-of-appointment that the consumer signs via SMS or email during the call.

Document everything. Keep the original form-fill consent in your CRM, the timestamp and language of the per-agent consent capture, and the disposition of any enrollment that follows.

This isn't dramatically harder than the pre-rule workflow, but it does require deliberate process discipline. CPA math factors in the slightly longer call time and the modest reduction in close rate that the consent capture adds, but the underlying economics still work. At a $5 aged MA lead, 25% contact rate, and a 2.5% compliance-aware conversion, you're at a $200 CPA against a $300-$500 first-year MA commission and a long renewal tail.

The math: three Medicare agents, same $1,000 budget

Same budget, different sub-market and lead-tier choices.

Agent A — buys real-time Medicare Advantage at $50/lead

Twenty leads. Speed-to-lead pressure with three to five competing buyers per record. Effective conversion 8% on contacts: 1.6 enrollments. At $300 first-year commission plus $300 first-year renewal credit: gross $960. Net of $1,000 lead spend: −$40. Breakeven on year-one, profitable on years two and three off the renewal tail.

Agent B — buys aged Medicare Advantage at $4/lead, post-October 2024 with TPMO consent

250 leads. 25% cumulative contact rate over 14-day cadence: 62 conversations. Compliance-aware conversion 3% (slightly lower than legacy aged MA conversion because the consent-capture step adds friction): 1.9 enrollments. Gross revenue: $930. Net: −$70. Similar year-one outcome to Agent A, but the renewal tail is the same and the cash flow shape is friendlier.

Agent C — buys aged Medicare Supplement at $3/lead

333 leads. 30% cumulative contact rate (slightly higher because the senior demographic is more reachable than the broader Medicare-eligible pool): 100 conversations. Conversion 4% (cleaner regulatory environment, simpler call flow): 4 sales. At $500 first-year commission: gross $2,000. Net: $1,000. Year-one ROI 100%. Renewal tail strong.

Three reasonable Medicare-focused agents. Same budget. Aged MedSupp produces the cleanest year-one math by a wide margin in 2026, primarily because the regulatory environment is less constrained than aged MA and the aged discount over real-time is enormous.

Open enrollment timing — when to buy and when to call

Health insurance has more pricing arbitrage opportunity than any other vertical because of the enrollment-period cycles. Buying aged inventory in the trough and calling during the peak is a real strategic edge.

ACA Open Enrollment: November 1 to January 15. Buy aged in April-July (post-prior-OEP price floor). Begin SEP-driven calls year-round. Ramp formal OEP outreach in September, with peak conversion November through January.

Medicare AEP: October 15 to December 7. Buy aged in February-April. Begin pre-AEP educational outreach in August. Peak enrollment activity October through December.

Medicare Advantage Open Enrollment Period (MA-OEP): January 1 to March 31. Existing MA enrollees can switch plans. Buy aged in September-November. Peak conversion January through March.

Medicare Supplement: year-round, but Birthday Rule states create local enrollment windows. Track your states' rules and buy timing-relevant inventory.

ACA Special Enrollment Periods: triggered by life events year-round. Aged ACA inventory is valuable continuously because SEP demand never stops — you just have to identify the eligible consumers from a larger volume of records.

How to vet a health insurance lead provider in 2026

The vendor questions that matter most for this vertical:

For Medicare Advantage specifically: ask for the original form's consent language, the date and time of submission, the originating URL, and whether the lead was originated pre or post October 1, 2024. A reputable provider has this data and will share it. A provider that won't is one you don't buy from for MA.

For all health verticals: standard TCPA documentation including the original disclosure URL, consent timestamp, and any DNC scrubbing performed at origination.

Bad-data rate: should be under 15% on legitimate aged inventory across all three sub-markets. Higher than that means the provider isn't refreshing skip-trace or NCOA data on their warehoused inventory.

Return policy: 20% return credit for verifiable bad data is industry standard. Some providers go higher.

Filtering: ZIP, state, age band (especially relevant for senior health), eligibility category, carrier exclusion (some buyers want to skip the major-carrier captive consumers), and exclusivity tier.

What should you pay? Check our Lead Price Index — fair market benchmarks updated monthly.

A practical playbook for 2026

If you're starting a health insurance aged-leads program, here's the sequence that usually works:

Pick the sub-market that matches your specialization. Don't try to run aged ACA, MedSupp, and MA campaigns simultaneously for your starter test. Pick one product, build the workflow, then add a second after 90 days of conversion data.

Start with $500-$1,000 in your sub-market's most operationally clean tier. For most agents in 2026, that's aged MedSupp 31-85 day shared at $3 per lead. ACA aged is the runner-up if you're year-round SEP focused. Aged MA requires more careful provider vetting before you start.

Build the consent-aware call flow before you make a single call. For MA specifically, draft your scope-of-appointment script and your per-agent consent capture before the leads land. For ACA and MedSupp, your standard TCPA framework is enough.

Track CPA by tier and CPA by carrier. Different carriers have different commission structures, retention curves, and renewal credits. Your aged-leads program will reveal which carrier-product combinations actually drive profit, not just enrollment volume.

Run a 90-day review (longer than auto, mortgage, or term life because health insurance commission tails are long). Compare your numbers to the worked examples above. Scale, refilter, or reallocate based on your actual conversion data.

What this means for you

Health insurance leads in 2026 are still a deeply favorable category for aged-leads buyers — but the operating environment is more textured than the pricing table alone suggests.

For agents writing ACA / individual health: aged inventory at sub-$1 per lead with year-round SEP conversion is the most defensible model in the category. Buy in the post-OEP price trough, work the SEP triggers continuously, ramp into peak OEP outreach in Q4.

For agents writing Medicare Supplement: aged MedSupp is the single most underrated tier in the entire health-insurance lead market. Cleanest regulatory frame, longest renewal tail, lowest pricing. Lead with MedSupp on senior aged inventory and cross-sell into MA where eligibility and timing align.

For agents writing Medicare Advantage: the CMS TPMO consent rule is the operational reality and isn't going away. Source aged MA from providers who can give you the consent regime and original-form documentation. Build a consent-aware call flow. Treat the workflow as a process discipline question, not a regulatory burden.

A few takeaways:

• The CMS TPMO consent rule (effective October 2024) is the single most important regulatory frame for aged Medicare Advantage in 2026 — and it doesn't apply to MedSupp.
• Aged MedSupp is the cleanest, highest-margin Medicare-segment inventory available in 2026.
• ACA aged inventory has a strong Q1-Q2 pricing arbitrage if you're willing to warehouse leads through the year and convert during OEP.
• Year-round SEP outreach on aged ACA inventory is the most under-deployed strategy in the under-65 health market.
• Provider vetting for Medicare leads in 2026 should explicitly include the consent regime under which the lead was originated. Don't accept "just trust us."

If you want to model the math against your own commission structure and carrier mix, you can browse aged inventory across all three health sub-markets at Aged Lead Store — they tag Medicare inventory by origination period and provide the per-lead TCPA documentation that the 2026 compliance posture requires. The pricing in the table at the top of this article reflects their current published rates.